NCT01488578View on ClinicalTrials.gov

Tolterodine Drug Use Investigation.(Post Marketing Commitment Plan)

CompletedOBSERVATIONAL
Enrollment

11,157

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

March 31, 2011

Study Completion Date

March 31, 2011

Conditions
Overactive Bladder
Interventions
DRUG

Tolterodine tartrate

Detrusitol Capsule 2mg and 4mg, depending on the Investigator prescription.Frequency and duration are according to Package Insert as follows.

All Listed Sponsors
lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT01488578 - Tolterodine Drug Use Investigation.(Post Marketing Commitment Plan) | Biotech Hunter | Biotech Hunter